EGFR and glioblastoma: It is important to note that the nonclassical glioblastomas (mesenchymal, proneural, and neural subtypes) frequently display NFKBIA (NF-kB Inhibitor-α, a modulator of NF-kB and EGFR signaling) gene deletions [11].